Juzentaihoto improves adenine-induced chronic renal failure in BALB/c mice via suppression of renal fibrosis and inflammation

• Main Authors: Satoyasu Ito (Author), Eri Manabe (Author), Yi Dai (Author), Masaharu Ishihara (Author), Takeshi Tsujino (Author)
• Formato: Libro
• Publicado: Elsevier, 2022-01-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Renal inflammation and fibrosis are observed in underlying diseases associated with the pathological progression of chronic kidney disease (CKD). The inhibition of renal inflammation and fibrosis is one method to suppress the progression of CKD. Juzentaihoto (TJ-48), a Kampo medicine, effectively re...